These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 23551291)
1. Postnatal steroids in extremely low birth weight infants: betamethasone or hydrocortisone? Ben Said M; Hays S; Loys CM; Coletto L; Godbert I; Picaud JC Acta Paediatr; 2013 Jul; 102(7):689-94. PubMed ID: 23551291 [TBL] [Abstract][Full Text] [Related]
2. [The use of postnatal corticosteroid therapy in premature infants to prevent or treat bronchopulmonary dysplasia: current situation and recommendations]. Jarreau PH; Fayon M; Baud O; Autret-Leca E; Danan M; de Verdelhan A; Castot A Arch Pediatr; 2010 Oct; 17(10):1480-7. PubMed ID: 20864322 [TBL] [Abstract][Full Text] [Related]
3. Postnatal betamethasone vs dexamethasone in premature infants with bronchopulmonary dysplasia: a pilot study. DeCastro M; El-Khoury N; Parton L; Ballabh P; LaGamma EF J Perinatol; 2009 Apr; 29(4):297-304. PubMed ID: 19052552 [TBL] [Abstract][Full Text] [Related]
4. Association between fluid intake and weight loss during the first ten days of life and risk of bronchopulmonary dysplasia in extremely low birth weight infants. Oh W; Poindexter BB; Perritt R; Lemons JA; Bauer CR; Ehrenkranz RA; Stoll BJ; Poole K; Wright LL; J Pediatr; 2005 Dec; 147(6):786-90. PubMed ID: 16356432 [TBL] [Abstract][Full Text] [Related]
5. Nutritional strategies and growth in extremely low birth weight infants with bronchopulmonary dysplasia over the past 10 years. Theile AR; Radmacher PG; Anschutz TW; Davis DW; Adamkin DH J Perinatol; 2012 Feb; 32(2):117-22. PubMed ID: 21617642 [TBL] [Abstract][Full Text] [Related]
6. Hydrocortisone treatment for bronchopulmonary dysplasia and brain volumes in preterm infants. Kersbergen KJ; de Vries LS; van Kooij BJ; Išgum I; Rademaker KJ; van Bel F; Hüppi PS; Dubois J; Groenendaal F; Benders MJ J Pediatr; 2013 Sep; 163(3):666-71.e1. PubMed ID: 23706359 [TBL] [Abstract][Full Text] [Related]
7. Association between early postnatal weight loss and death or BPD in small and appropriate for gestational age extremely low-birth-weight infants. Wadhawan R; Oh W; Perritt R; Laptook AR; Poole K; Wright LL; Fanaroff AA; Duara S; Stoll BJ; Goldberg R J Perinatol; 2007 Jun; 27(6):359-64. PubMed ID: 17443198 [TBL] [Abstract][Full Text] [Related]
8. [Glucocorticoide therapy in premature infants: French practices in 2006]. Autret-Leca E; Bauer S; Alberti C; Jonville-Béra AP; Aujard Y; Bensouda-Grimaldi L; Baud O Arch Pediatr; 2009 Jul; 16(7):999-1004. PubMed ID: 19410441 [TBL] [Abstract][Full Text] [Related]
9. Neurodevelopment at 24 months corrected age in extremely preterm infants treated with dexamethasone alternatives during the late postnatal period: a cohort study. Melan N; Pradat P; Godbert I; Pastor-Diez B; Basson E; Picaud JC Eur J Pediatr; 2024 Feb; 183(2):677-687. PubMed ID: 37955745 [TBL] [Abstract][Full Text] [Related]
10. A randomized-controlled trial of prophylactic hydrocortisone supplementation for the prevention of hypotension in extremely low birth weight infants. Efird MM; Heerens AT; Gordon PV; Bose CL; Young DA J Perinatol; 2005 Feb; 25(2):119-24. PubMed ID: 15329742 [TBL] [Abstract][Full Text] [Related]
11. Betamethasone vs dexamethasone for the prevention of morbidity in very-low-birthweight neonates. Feldman DM; Carbone J; Belden L; Borgida AF; Herson V Am J Obstet Gynecol; 2007 Sep; 197(3):284.e1-4. PubMed ID: 17826422 [TBL] [Abstract][Full Text] [Related]
12. Time-related changes in steroid use and bronchopulmonary dysplasia in preterm infants. Yoder BA; Harrison M; Clark RH Pediatrics; 2009 Aug; 124(2):673-9. PubMed ID: 19620192 [TBL] [Abstract][Full Text] [Related]
13. Hydrocortisone use in ventilated extremely preterm infants decreased bronchopulmonary dysplasia with no effects on neurodevelopment after two years. Renault A; Patkaï J; Dassieu G; El Ayoubi M; Canouï-Poitrine F; Durrmeyer X Acta Paediatr; 2016 Sep; 105(9):1047-55. PubMed ID: 27239054 [TBL] [Abstract][Full Text] [Related]
14. Hydrocortisone vs. dexamethasone treatment for bronchopulmonary dysplasia and their effects on general movements in preterm infants. Hitzert MM; Benders MJ; Roescher AM; van Bel F; de Vries LS; Bos AF Pediatr Res; 2012 Jan; 71(1):100-6. PubMed ID: 22289857 [TBL] [Abstract][Full Text] [Related]
17. A controlled trial of dexamethasone to prevent bronchopulmonary dysplasia in surfactant-treated infants. Rastogi A; Akintorin SM; Bez ML; Morales P; Pildes RS Pediatrics; 1996 Aug; 98(2 Pt 1):204-10. PubMed ID: 8692619 [TBL] [Abstract][Full Text] [Related]
18. Short-term outcomes in low birth weight infants following antenatal exposure to betamethasone versus dexamethasone. Bar-Lev MR; Maayan-Metzger A; Matok I; Heyman Z; Sivan E; Kuint J Obstet Gynecol; 2004 Sep; 104(3):484-8. PubMed ID: 15339757 [TBL] [Abstract][Full Text] [Related]
19. Improved care and growth outcomes by using hybrid humidified incubators in very preterm infants. Kim SM; Lee EY; Chen J; Ringer SA Pediatrics; 2010 Jan; 125(1):e137-45. PubMed ID: 20026493 [TBL] [Abstract][Full Text] [Related]
20. Trial of beclomethasone dipropionate by metered-dose inhaler in ventilator-dependent neonates less than 1500 grams. Giep T; Raibble P; Zuerlein T; Schwartz ID Am J Perinatol; 1996 Jan; 13(1):5-9. PubMed ID: 8645387 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]